Fresenius Kabi Recalls Haloperidol Decanoate Injection Due to Impurity
Fresenius Kabi USA, LLC is recalling Haloperidol Decanoate Injection due to an impurity out-of-specification result. The recall affects 48,210 units distributed nationwide and in Puerto Rico.
- Product
- HALOPERIDOL DECANOATE — HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)
- Category
- Drug
- Distribution
- Distributed nationwide